Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Clarissa Patrizi
In Hepatocellular Carcinoma miR-221 Modulates Sorafenib Resistance Through Inhibition of Caspase-3–Mediated Apoptosis
Clinical Cancer Research
Cancer Research
Oncology
Related publications
TARBP2-mediated Destabilization of Nanog Overcomes Sorafenib Resistance in Hepatocellular Carcinoma
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
Hypoxia-Mediated Mitochondria Apoptosis Inhibition Induces Temozolomide Treatment Resistance Through miR-26a/Bad/Bax Axis
Cell Death and Disease
Molecular Neuroscience
Immunology
Cell Biology
Cancer Research
Cellular
Medicine
Sorafenib in Hepatocellular Carcinoma
Clinical Medicine. Therapeutics
Growth Inhibition and Apoptosis Induction by (+)-Cyanidan-3-Ol in Hepatocellular Carcinoma
PLoS ONE
Multidisciplinary
Pterostilbene Inhibits Hepatocellular Carcinoma Through P53/Sod2/ROS-mediated Mitochondrial Apoptosis
Oncology Reports
Medicine
Cancer Research
Oncology
The Microenvironmental and Metabolic Aspects of Sorafenib Resistance in Hepatocellular Carcinoma
EBioMedicine
Biochemistry
Medicine
Genetics
Molecular Biology
Caspase-3-Mediated Cleavage of Rad9 During Apoptosis
Oncogene
Cancer Research
Genetics
Molecular Biology
Suppression of P53 by Notch3 Is Mediated by Cyclin G1 and Sustained by MDM2 and miR-221 Axis in Hepatocellular Carcinoma
Oncotarget
Oncology
MiR-122 Reverses the Doxorubicin-Resistance in Hepatocellular Carcinoma Cells Through Regulating the Tumor Metabolism
PLoS ONE
Multidisciplinary